About Kinvan
Kinvan is a company based in India. It operates as a B2B. The company has 301 employees as of March 31, 2023. Kinvan offers products and services including AVICIL Stabilised Potassium Clavulanate, SiO2 Stabilised Potassium Clavulanate, and Potassium Clavulanate + Amoxycillin (1:5).
- Headquarter India
- Employees 301 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Kinvan Private Limited
- Date of Incorporation 10 Oct, 2020
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
301
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kinvan
Kinvan offers a comprehensive portfolio of products and services, including AVICIL Stabilised Potassium Clavulanate, SiO2 Stabilised Potassium Clavulanate, and Potassium Clavulanate + Amoxycillin (1:5).
Inhibits beta-lactamase to enhance penicillin effectiveness against bacteria.
Stabilizes Clavulanate for use in pharmaceutical formulations.
Combines with Amoxycillin to treat resistant bacterial infections.
Funding Insights of Kinvan
Detailed funding history for Kinvan
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kinvan
Investment portfolio details for Kinvan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kinvan
Detailed financials for Kinvan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kinvan Comparisons
Peer comparison for Kinvan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kinvan
Detailed competitors of Kinvan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kinvan
Complete news archive for Kinvan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kinvan
Kinvan is headquartered in India.
As of Mar 31, 2023, the latest employee count at Kinvan is 301.
Kinvan Private Limited, incorporated in 2020, produces Clavulanic Acid through fermentation processes as part of Indias Production Linked Incentive Scheme. It focuses on key starting materials and active pharmaceutical ingredients for overcoming bacterial resistance in antibiotics. The company operates from its manufacturing facility in Nalagarh, Himachal Pradesh, and registered office in Mumbai, supplying to the pharmaceutical industry with a commitment to domestic production.
Kinvan offers AVICIL Stabilised Potassium Clavulanate, SiO2 Stabilised Potassium Clavulanate, and Potassium Clavulanate + Amoxycillin (1:5).